Compounds > niacinamide
Page last updated: 2024-10-19

niacinamide and Dermatitis Exfoliativa

niacinamide has been researched along with Dermatitis Exfoliativa in 2 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Research Excerpts

ExcerptRelevanceReference
"Sorafenib treatment was initiated a 400 mg orally twice a day."1.35Generalised erythematous skin eruptions induced by sorafenib: cutaneous toxicity and treatment outcome. ( Borrás-Blasco, J; Casterá, ME; Galán Brotons, A; Rosique-Robles, JD; Vicent Verge, JM, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galán Brotons, A1
Borrás-Blasco, J1
Rosique-Robles, JD1
Vicent Verge, JM1
Casterá, ME1

Reviews

1 review available for niacinamide and Dermatitis Exfoliativa

ArticleYear
Sorafenib (Nexavar) for thyroid cancer.
    The Medical letter on drugs and therapeutics, 2014, May-26, Volume: 56, Issue:1443

    Topics: Animals; Antineoplastic Agents; Dermatitis, Exfoliative; Humans; Niacinamide; Phenylurea Compounds;

2014

Other Studies

1 other study available for niacinamide and Dermatitis Exfoliativa

ArticleYear
Generalised erythematous skin eruptions induced by sorafenib: cutaneous toxicity and treatment outcome.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:12

    Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Dermatitis, Exfoliative; Drug Erupt

2008